Article

CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer

Disease Markers · 2020 · Zhenkun Ma, author Ye Gao, author Wei Liu, author Long Zheng, author Ben Jin, author Bei Duan, author Hongjun Xie, author Peng Guo, author Jin Zeng, author Ke Wang, author Shan Xu, author Xinyang Wang, author Dalin He, author Lei Li, author Jian Ma, Academic Editor

Key facts

Title CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer
First author Zhenkun Ma, author Ye Gao, author Wei Liu, author Long Zheng, author Ben Jin, author Bei Duan, author Hongjun Xie, author Peng Guo, author Jin Zeng, author Ke Wang, author Shan Xu, author Xinyang Wang, author Dalin He, author Lei Li, author Jian Ma, Academic Editor
Journal Disease Markers
Published Aug 21, 2020
DOI 10.1155/2020/8899924
Product codes mentioned GIA

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature